The ALS Drug Development Summit unites a strong community across discovery, biology, preclinical, translational, clinical and regulatory experts from across large pharma and biotech as well as key stakeholders from academics, funding, research organizations and patients. Together we aim to leverage emerging breakthroughs and drive impactful research to advance treatments and ultimately a cure for sporadic and familial ALS.

Date: May 12-14, 2025
Location: Boston, MA

www.als-drug-development.com

JOIN US!

Join us at the ALS Drug Development Summit to learn how Catalent can support your drug development journey with our Zydis® ODT technology, which advances patient-centric therapies through enhanced ease of administration and improved adherence. Schedule a meeting today!

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Poster: Improving Dysphagic Patient Compliance with Zydis® ODT
Michael Sarmento, Senior Account Director
David Sebesta, Senior Account Director
Tuesday, May 13, 2023 | 3:00 pm ET

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.

 

 

More products. Better treatments. Reliably supplied.™